Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Is hyperprogressive disease a specific phenomenom of immunotherapy?

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • Contributors:
      Brambilla, Marta; Lo Russo, Giuseppe; Ferrara, Roberto; Manglaviti, Sara; Garassino, Marina Chiara; Occhipinti, Mario
    • بيانات النشر:
      Open Exploration
    • الموضوع:
      2020
    • Collection:
      Sapienza Università di Roma: CINECA IRIS
    • نبذة مختصرة :
      Hyperprogressive disease (HPD) is a novel pattern of response during immunotherapy treatment. Several retrospective studies have evaluated its prevalence among various cancer types and, in particular, in non-small cell lung cancer patients, based on different definition criteria. If HPD is a just a typical phenomenon of immunotherapy is still an unsolved concern. This paper summarized the available data about HPD in other cancer treatments. Hyperprogressive disease (HPD) is a novel pattern of response during immunotherapy treatment. Several retrospective studies have evaluated its prevalence among various cancer types and, in particular, in non-small cell lung cancer patients, based on different definition criteria. If HPD is a just a typical phenomenon of immunotherapy is still an unsolved concern. This paper summarized the available data about HPD in other cancer treatments.
    • Relation:
      volume:1; issue:6; firstpage:427; lastpage:433; numberofpages:7; journal:EXPLORATION OF TARGETED ANTI-TUMOR THERAPY; http://hdl.handle.net/11573/1484313; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85128272259
    • الرقم المعرف:
      10.37349/etat.2020.00027
    • الدخول الالكتروني :
      http://hdl.handle.net/11573/1484313
      https://doi.org/10.37349/etat.2020.00027
    • Rights:
      info:eu-repo/semantics/openAccess
    • الرقم المعرف:
      edsbas.645B8302